{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T06:41:54Z","timestamp":1778395314686,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670380"],"award-info":[{"award-number":["81670380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2018YFC1315100"],"award-info":[{"award-number":["2018YFC1315100"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bcp.2025.116897","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T09:20:31Z","timestamp":1742980831000},"page":"116897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["xCT\/Slc7a11 promotes pulmonary arterial hypertension by disrupting AMPK\u03b1 suppression of mTOR activation"],"prefix":"10.1016","volume":"236","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0002-6038","authenticated-orcid":false,"given":"Yan","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenqiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianmei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.116897_b0005","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J."},{"key":"10.1016\/j.bcp.2025.116897_b0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41569-019-0242-x","article-title":"Molecular genetic framework underlying pulmonary arterial hypertension","volume":"17","author":"Southgate","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"10.1016\/j.bcp.2025.116897_b0015","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01887-2018","article-title":"Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives","volume":"53","author":"Humbert","year":"2019","journal-title":"Eur Respir J."},{"key":"10.1016\/j.bcp.2025.116897_b0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00395-020-00826-8","article-title":"The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice","volume":"115","author":"Batool","year":"2020","journal-title":"Basic Res Cardiol."},{"key":"10.1016\/j.bcp.2025.116897_b0025","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1242\/dev.137075","article-title":"Proliferation, survival and metabolism: the role of PI3K\/AKT\/mTOR signalling in pluripotency and cell fate determination","volume":"143","author":"Yu","year":"2016","journal-title":"Development"},{"key":"10.1016\/j.bcp.2025.116897_b0030","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR Signaling in Growth, Metabolism, and Disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.116897_b0035","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jacbts.2018.08.009","article-title":"Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension","volume":"3","author":"Tang","year":"2018","journal-title":"JACC Basic Transl Sci."},{"key":"10.1016\/j.bcp.2025.116897_b0040","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1165\/rcmb.2017-0245ED","article-title":"mTOR: A Key to Both Pulmonary Vessel Remodeling and Right Ventricular Function in Pulmonary Arterial Hypertension?","volume":"57","author":"Houssaini","year":"2017","journal-title":"Am J Respir Cell Mol Biol."},{"key":"10.1016\/j.bcp.2025.116897_b0045","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jacbts.2018.08.003","article-title":"TORward a Molecular Convergence Point in Pulmonary Arterial Hypertension With mTOR","volume":"3","author":"Maron","year":"2018","journal-title":"JACC Basic Transl Sci."},{"key":"10.1016\/j.bcp.2025.116897_b0050","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat Cell Biol."},{"key":"10.1016\/j.bcp.2025.116897_b0055","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-pharmtox-010611-134537","article-title":"AMPK and mTOR in cellular energy homeostasis and drug targets","volume":"52","author":"Inoki","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"10.1016\/j.bcp.2025.116897_b0060","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.115.018935","article-title":"SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction","volume":"133","author":"Lai","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2025.116897_b0065","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/CIRCRESAHA.115.308178","article-title":"Protective Roles of Endothelial AMP-Activated Protein Kinase Against Hypoxia-Induced Pulmonary Hypertension in Mice","volume":"119","author":"Omura","year":"2016","journal-title":"Circ Res."},{"key":"10.1016\/j.bcp.2025.116897_b0070","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1164\/rccm.201712-2570OC","article-title":"AMP-activated Protein Kinase Phosphorylation of Angiotensin-Converting Enzyme 2 in Endothelium Mitigates Pulmonary Hypertension","volume":"198","author":"Zhang","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.bcp.2025.116897_b0075","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/s41418-019-0274-0","article-title":"mTOR-dependent upregulation of xCT blocks melanin synthesis and promotes tumorigenesis","volume":"26","author":"Li","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2025.116897_b0080","first-page":"12","article-title":"Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer","volume":"38","author":"Koppula","year":"2018","journal-title":"Cancer Commun (lond)."},{"key":"10.1016\/j.bcp.2025.116897_b0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/cas.14224","article-title":"Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy","volume":"111","author":"Otsuki","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bcp.2025.116897_b0090","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1086\/678508","article-title":"The Sugen 5416\/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up","volume":"4","author":"Vitali","year":"2014","journal-title":"Pulm Circ."},{"key":"10.1016\/j.bcp.2025.116897_b0095","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cmi.2023.01.021","article-title":"Pharmacokinetics\/pharmacodynamics of phage therapy: a major hurdle to clinical translation","volume":"29","author":"Nang","year":"2023","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.bcp.2025.116897_b0100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-8597-5_19","article-title":"The Sugen 5416\/Hypoxia Mouse Model of Pulmonary Arterial Hypertension","volume":"1816","author":"Bueno-Beti","year":"2018","journal-title":"Methods Mol Biol."},{"key":"10.1016\/j.bcp.2025.116897_b0105","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1172\/JCI137558","article-title":"Hypoxia-inducible factor signaling in pulmonary hypertension","volume":"130","author":"Pullamsetti","year":"2020","journal-title":"J Clin Invest."},{"key":"10.1016\/j.bcp.2025.116897_b0110","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2011.01.038","article-title":"CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth","volume":"19","author":"Ishimoto","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2025.116897_b0115","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein","author":"Koppula","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.116897_b0120","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.2174\/0929867325666171226114838","article-title":"Role of Redox Homeostasis and Inflammation in the Pathogenesis of Pulmonary Arterial Hypertension","volume":"25","author":"Bello-Klein","year":"2018","journal-title":"Curr Med Chem."},{"key":"10.1016\/j.bcp.2025.116897_b0125","doi-asserted-by":"crossref","first-page":"D4","DOI":"10.1016\/j.jacc.2013.10.025","article-title":"Relevant issues in the pathology and pathobiology of pulmonary hypertension","volume":"62","author":"Tuder","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.bcp.2025.116897_b0130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1165\/rcmb.2018-0231OC","article-title":"Endothelial-Mesenchymal Transition Drives Expression of CD44 Variant and xCT in Pulmonary Hypertension","volume":"61","author":"Isobe","year":"2019","journal-title":"Am J Respir Cell Mol Biol."},{"key":"10.1016\/j.bcp.2025.116897_b0135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nm.3040","article-title":"An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension","volume":"19","author":"Kim","year":"2013","journal-title":"Nat Med."},{"key":"10.1016\/j.bcp.2025.116897_b0140","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/HYPERTENSIONAHA.122.19857","article-title":"Targeting Endothelial ENO1 (Alpha-Enolase) -PI3K-Akt-mTOR Axis Alleviates Hypoxic Pulmonary Hypertension","volume":"80","author":"Shi","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2025.116897_b0145","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1165\/rcmb.2012-0429OC","article-title":"Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension","volume":"48","author":"Houssaini","year":"2013","journal-title":"Am J Respir Cell Mol Biol."},{"key":"10.1016\/j.bcp.2025.116897_b0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1465-9921-8-15","article-title":"Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice","volume":"8","author":"Paddenberg","year":"2007","journal-title":"Respir Res."},{"key":"10.1016\/j.bcp.2025.116897_b0155","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ncb2168","article-title":"Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1","volume":"13","author":"Zheng","year":"2011","journal-title":"Nat Cell Biol."},{"key":"10.1016\/j.bcp.2025.116897_b0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41420-020-0260-9","article-title":"How does mTOR sense glucose starvation? AMPK is the usual suspect","volume":"6","author":"Leprivier","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bcp.2025.116897_b0165","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1476-5381.2009.00445.x","article-title":"Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension","volume":"158","author":"Agard","year":"2009","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.bcp.2025.116897_b0170","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/HYPERTENSIONAHA.116.07353","article-title":"Metformin Reverses Development of Pulmonary Hypertension via Aromatase Inhibition","volume":"68","author":"Dean","year":"2016","journal-title":"Hypertension"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225001595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225001595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:22:40Z","timestamp":1762096960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225001595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"alternative-id":["S0006295225001595"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116897","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"xCT\/Slc7a11 promotes pulmonary arterial hypertension by disrupting AMPK\u03b1 suppression of mTOR activation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116897","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116897"}}